Comparison Taysha Gene Therapies (TSHA) with Competitors
Taysha Gene Therapies (TSHA) industry is Biotechnology.
Operating Margin
TSHA-1774.00%
Industry-2055.25%
Upside+281.25%
Debt-to-Equity
TSHA23.10%
Industry28.27%
Upside-18.28%
Free Cash Flow Yield
TSHA-6.34%
Industry-1.75%
Upside-4.59%
P/E
TSHA-13.36
Industry-20.52
Upside+715.95%
P/S
TSHA238.09
Industry10.01
Upside+2277.68%
P/B
TSHA7.72
Industry5.15
Upside+50.00%